within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AX18_Letermovir;

model Letermovir
  extends Pharmacolibrary.Drugs.ATC.J.J05AX18;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J05AX18</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Letermovir is an antiviral medication approved for the prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT). It works as a CMV DNA terminase complex inhibitor and is currently approved and in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic model parameters for healthy adult subjects, mainly following oral administration, as reported in published population pharmacokinetic studies.</p><h4>References</h4><ol><li><p>Scheuenpflug, J, et al., &amp; Rübsamen-Schaeff, H (2022). The Effect of Oral Letermovir Administration on the Pharmacokinetics of a Single Oral Dose of P-Glycoprotein Substrate Digoxin in Healthy Volunteers. <i>Clinical pharmacology in drug development</i> 11(1) 6–15. DOI:<a href=\"https://doi.org/10.1002/cpdd.1043\">10.1002/cpdd.1043</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34812580/\">https://pubmed.ncbi.nlm.nih.gov/34812580</a></p></li><li><p>Prohn, M, et al., &amp; Cho, CR (2021). Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients. <i>CPT: pharmacometrics &amp; systems pharmacology</i> 10(3) 255–267. DOI:<a href=\"https://doi.org/10.1002/psp4.12593\">10.1002/psp4.12593</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33440077/\">https://pubmed.ncbi.nlm.nih.gov/33440077</a></p></li><li><p>Suetsugu, K, et al., &amp; Ieiri, I (2024). Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation. <i>Clinical pharmacokinetics</i> 63(7) 945–964. DOI:<a href=\"https://doi.org/10.1007/s40262-024-01392-1\">10.1007/s40262-024-01392-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39012618/\">https://pubmed.ncbi.nlm.nih.gov/39012618</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Letermovir;
